** Shares of biotech firm Virpax Pharmaceuticals VRPX.O fall 55.2% to 54 cents
** VRPX's stock to be delisted from Nasdaq tomorrow for failing to meet minimum stockholders' equity requirement - SEC filing
** Co does not plan to appeal the delisting decision
** Three board members and CFO, Usama Chaudhry, have resigned from their positions, effective immediately
** Including session's move, stock down 94% YTD
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。